NO20044979L - Nye biomaterialer, deres fremstilling og anvendelse - Google Patents

Nye biomaterialer, deres fremstilling og anvendelse

Info

Publication number
NO20044979L
NO20044979L NO20044979A NO20044979A NO20044979L NO 20044979 L NO20044979 L NO 20044979L NO 20044979 A NO20044979 A NO 20044979A NO 20044979 A NO20044979 A NO 20044979A NO 20044979 L NO20044979 L NO 20044979L
Authority
NO
Norway
Prior art keywords
precipitate
components
additional
component
amphilic
Prior art date
Application number
NO20044979A
Other languages
English (en)
Inventor
Gyorgy Lajos Kis
Lajos Szente
Christian Schoch
Jozsef Szejtli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20044979L publication Critical patent/NO20044979L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Foreliggende oppfinnelse angår nye materialer, særlig biomaterialer, i form av et presipitat, som innbefatter minst en anionisk polymerkomponent som sådan er løselig i vann og en amfilisk ammoniumtypekomponent, hvilket presipitat oppnås ved en fremgangsmåte som inkluderer følgende trinn: 1. bringe den anioniske polymerkomponenten og en cyklodekstrinkomponent i kontakt i et vandig medium, og 2. tilsette til blandingen oppnådd i trinn 1 nevnte amfiliske ammoniumtypekomponent, hvori nevnte komponenter er tilstede i mengder effektive til å danne nevnte presipitat, og foretrukket for de korresponderende presipitatene innbefatter de ytterligere nevnte cyklodekstrinkomponent. Begge typer presipitat kan eventuelt innbefatte en eller flere ytterligere komponenter. Presipitatene er særlig anvendelige for kontrollert frigivelses depotformuleringer egnet for langtidsvirkende levering av nevnte ytterligere komponenter. De ytterligere komponentene inkorporert i presipitatene kan være farmasøytiske forbindelser, pesticider, agrokjemikalier, fargestoffer, diagnostiske midler, enzymer, matvarer etc.
NO20044979A 2002-04-19 2004-11-16 Nye biomaterialer, deres fremstilling og anvendelse NO20044979L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02008809 2002-04-19
PCT/EP2003/004076 WO2003089008A1 (en) 2002-04-19 2003-04-17 Novel biomaterials, their preparation and use

Publications (1)

Publication Number Publication Date
NO20044979L true NO20044979L (no) 2004-11-16

Family

ID=29225593

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044979A NO20044979L (no) 2002-04-19 2004-11-16 Nye biomaterialer, deres fremstilling og anvendelse

Country Status (20)

Country Link
US (3) US20050163853A1 (no)
EP (1) EP1499361B1 (no)
JP (1) JP4648632B2 (no)
KR (1) KR101121675B1 (no)
CN (1) CN1646171B (no)
AU (1) AU2003224099B2 (no)
BR (1) BR0309340A (no)
CA (1) CA2484100C (no)
CO (1) CO5611168A2 (no)
ES (1) ES2392964T3 (no)
HK (1) HK1073070A1 (no)
IL (1) IL164627A (no)
MX (1) MXPA04010325A (no)
NO (1) NO20044979L (no)
NZ (1) NZ535810A (no)
PL (1) PL215579B1 (no)
PT (1) PT1499361E (no)
RU (1) RU2321597C2 (no)
WO (1) WO2003089008A1 (no)
ZA (1) ZA200407794B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
AU2005209201B2 (en) * 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
WO2006011044A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Amorphous cyclodextrin compositions
US20060089590A1 (en) * 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
DK1787658T3 (da) 2005-11-10 2012-06-25 Chemi Spa Formuleringer med forsinket frigørelse og indeholdende somatostatin-analoge væksthormoninhibitorer
US20100155242A1 (en) * 2006-09-04 2010-06-24 Arkray, Inc. Method of Analyzing a Sample by Capillary Electrophoresis
JP2009186445A (ja) * 2008-02-08 2009-08-20 Arkray Inc キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬
CN101501484B (zh) * 2006-09-04 2012-12-26 独立行政法人产业技术综合研究所 通过毛细管电泳法分析试样的方法
EP2060913B1 (en) * 2006-09-04 2016-11-02 National Institute of Advanced Industrial Science and Technology Method for analysis of sample by capillary electrophoresis
NO2792369T3 (no) 2009-02-25 2018-09-15
US8389558B2 (en) * 2009-07-20 2013-03-05 Supratek Pharma Inc. Bendamustine amphiphilic anionic compositions
US20110015245A1 (en) * 2009-07-20 2011-01-20 Valery Alakhov Bendamustine amphiphilic cationic compositions
JP2013521796A (ja) 2010-03-13 2013-06-13 イーストポンド・ラボラトリーズ・リミテッド 脂肪結合性組成物
US8383663B2 (en) 2010-07-19 2013-02-26 Supratek Pharma Inc. Bendamustine anionic-catioinic cyclopolysaccharide compositions
US20120171184A1 (en) 2010-12-31 2012-07-05 Lajos Szente Cellular hydration compositions
BR112013016809A2 (pt) 2010-12-31 2016-09-27 Eastpond Lab Ltd composições de hidratação celular
BR112013018933A2 (pt) * 2011-02-10 2016-09-13 Unilever Nv composições antiviral, antisséptica líquida, e sólida para a lavagem pessoal, de limpeza sólida e líquida da superfície rígida, antimicrobiana, higienizadora de mãos, método de desinfecção de uma superfície e utilização de uma composição
BR112014017675B1 (pt) 2012-01-18 2021-06-22 Surmodics, Inc Revestimento para um dispositivo médico lubrificante com teor baixo de particulados, dispositivo médico e método de produção do mesmo
CA2932532C (en) * 2012-12-04 2021-06-22 Phosphorex, Inc. Microparticles and nanoparticles having negative surface charges
AU2014265275B2 (en) * 2013-05-17 2019-10-03 Marquette University Composite materials containing structural polysaccharides and macrocyclic compounds formed from ionic liquid compositions
JP5673756B2 (ja) * 2013-08-20 2015-02-18 東洋紡株式会社 医療用材料
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
EP3313364B1 (en) 2015-06-24 2019-10-23 Kao Germany GmbH Hair treatment process
US10342898B2 (en) * 2015-12-29 2019-07-09 Surmodics, Inc. Lubricious coatings with surface salt groups
US11174447B2 (en) 2015-12-29 2021-11-16 Surmodics, Inc. Lubricious coatings with surface salt groups
DK3528856T3 (da) 2016-10-18 2023-10-16 Univ Marquette Kompositmaterialer, der indeholder strukturelle polymerer og fotoreaktive nitrogenoxidfrigørende midler og anvendelser deraf til sårbandager
EP4132294A1 (en) 2020-04-06 2023-02-15 Eastpond Laboratories Limited Compositions for promoting cellular hydration
CN114344557A (zh) * 2022-01-10 2022-04-15 山东万容生物科技有限公司 一种含环糊精的水胶体敷料及其制备方法
WO2023212740A1 (en) * 2022-04-29 2023-11-02 Drexel University Surfactant-impregnated mof-coated fabric for antimicrobial applications

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670837A (no) * 1964-10-14 1966-01-31
JPS61251616A (ja) * 1985-04-30 1986-11-08 Agency Of Ind Science & Technol 溶質の放出量の制御方法
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
JPH03234770A (ja) * 1990-02-09 1991-10-18 Nippon Shokubai Kagaku Kogyo Co Ltd 電気刺激応答性ゲルの製法
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
JPH08134134A (ja) * 1994-11-09 1996-05-28 Nippon Shokubai Co Ltd 粒子状含水ゲル重合体の乾燥方法
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH0995413A (ja) * 1995-09-29 1997-04-08 Shiseido Co Ltd 皮膚外用剤
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000004916A1 (en) * 1998-07-23 2000-02-03 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Encapsulation of water soluble peptides
WO2000041541A2 (en) * 1999-01-12 2000-07-20 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof
JP2001318350A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ用溶液
AU6140301A (en) * 2000-05-15 2001-11-26 Procter & Gamble Compositions comprising cyclodextrin
US20020147232A1 (en) * 2000-05-26 2002-10-10 Claus Sundgreen Pharmaceutical compositions comprising desglymidodrine as an active drug substance
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds

Also Published As

Publication number Publication date
WO2003089008A1 (en) 2003-10-30
KR20040103968A (ko) 2004-12-09
EP1499361B1 (en) 2012-08-08
PL371595A1 (en) 2005-06-27
US20050163853A1 (en) 2005-07-28
NZ535810A (en) 2007-11-30
CO5611168A2 (es) 2006-02-28
IL164627A (en) 2009-11-18
CN1646171A (zh) 2005-07-27
CA2484100C (en) 2012-01-03
CA2484100A1 (en) 2003-10-30
PL215579B1 (pl) 2013-12-31
RU2321597C2 (ru) 2008-04-10
JP2005529879A (ja) 2005-10-06
AU2003224099B2 (en) 2006-11-09
ES2392964T3 (es) 2012-12-17
EP1499361A1 (en) 2005-01-26
MXPA04010325A (es) 2005-06-08
AU2003224099A1 (en) 2003-11-03
US20080299166A1 (en) 2008-12-04
IL164627A0 (en) 2005-12-18
HK1073070A1 (en) 2005-09-23
RU2004133887A (ru) 2005-10-20
JP4648632B2 (ja) 2011-03-09
ZA200407794B (en) 2006-02-22
US20120040901A1 (en) 2012-02-16
CN1646171B (zh) 2010-05-26
PT1499361E (pt) 2012-11-22
BR0309340A (pt) 2005-03-08
KR101121675B1 (ko) 2012-03-13

Similar Documents

Publication Publication Date Title
NO20044979L (no) Nye biomaterialer, deres fremstilling og anvendelse
BRPI0418622A (pt) plantas auto-processantes e partes de planta
BR0313226A (pt) Uso de agentes de floculação para separar resìduo sólido em substratos de fermentação hidrolisados
Rente et al. Review of deep eutectic systems from laboratory to industry, taking the application in the cosmetics industry as an example
WO2005061672A3 (en) Method of decomposition polymer
BR0212654A (pt) Ativação e expansão de células
BR9813968A (pt) Moléculas de ácido nucléico que codificam proteìnas tendo atividade frutosil transferase e processos para produzir inulina de cadeia longa
WO2008125120A3 (en) Extract of trigonella foenum-graecum
BR0211028A (pt) Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto
WO2008021574A8 (en) Modulating plant carotenoid levels
NO20034853D0 (no) Fargestoffer innkapslet i en polymermatrise
AU2003234956A1 (en) Pesticidal pyridinecarboxamide derivatives
WO2009134996A3 (en) Method of conditioning a mixed liquor containing nonionic polysaccharides and/or nonionic organic molecules
BR9803727A (pt) Tintas biostáveis de base em água e processo para suas preparações.
Rios et al. Pyruvate aldol condensation product: a metabolite that escaped synthetic preparation for over a century
Hainal et al. Lignin as a carbon source for the cultivation of some Rhodotorula species
Kim et al. Geopolymerization of biopolymers: a preliminary inquiry
JP2008072961A (ja) 高分子タンニンの酵素的架橋反応
AU7250601A (en) Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes
AU2003263914A1 (en) Rosin-fatty acid vinylic polymer compositions
Usharani et al. Stabilization of collagen through bioconversion: An insight in protein–protein interaction
BR0115242A (pt) Processo para a preparação de uma resina alquìdica modificada por acrìlico, resina alquìdica modificada por acrìlico, processo para a preparação de uma composição de resina alquìdica modificada por acrìlico transportada por água, e, composições de resina alquìdica modificada por acrìlico transportada por água, e de revestimento
CN103880139A (zh) 一种天然高分子絮凝剂及其制备方法
Zhao et al. Preparation and Investigation of a Fully Biobased Adhesive Composed of Gum Arabic and Soy Protein Isolate for Plywood
CN111138561A (zh) 一种基于高压剪切效应的壳寡糖绿色制备工艺

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application